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Abstract
Introduction. Little is known about the roles that lifetime psychiatric disorders play in psychiatric and vocational outcomes of
aneurysmal subarachnoid haemorrhage (SAH).
Materials and methods. Eighty-three SAH patients without apparent cognitive dysfunction were assessed using the
Structured Clinical Interview for DSM-IV axis I disorders (SCID-I) after their SAH. Diagnoses were assessed for three time
periods, ‘lifetime before SAH’, ‘12 months before SAH’ and ‘7 months after SAH’.
Results. Forty-ﬁve percentage of patients with SAH reported at least one lifetime psychiatric disorder. After SAH, symptoms
of depression and/or post-traumatic stress disorder (PTSD) were seen in 41%, more often in those with a psychiatric history
prior to SAH (p¼0.001). In logistic regressions, depression after SAH was associated with a lifetime history of major
depression, or of anxiety or substance use disorder, as well as with lifetime psychiatric comorbidity. Subsyndromal or full
PTSD was predicted by a lifetime history of major depression. After the SAH, 18 patients (22%) had received psychotropic
medication and/or psychological treatment, 13 of whom had a disorder. Those with a lifetime history of major depression or
treatment with antidepressants before SAH had lower return to work rates than others (p¼0.019 and p¼0.031,
respectively). This was also true for those with symptoms of depression and/or PTSD, or with antidepressant treatment after
SAH (p¼0.001 and p¼0.031, respectively).
Conclusions. Depression and PTSD are present in a substantial proportion of patients 7 months after SAH. Those with a
history of psychiatric morbidity, any time before the SAH, are more at risk and also constitute a risk group for difﬁculties in
returning to work.
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Introduction
A number of studies suggest that patients afﬂicted
with subarachnoid haemorrhage (SAH) have a
considerable burden of psychopathology in its after-
math, such as depression and post-traumatic stress
disorder (PTSD). The presence of depression,
anxiety and PTSD is strongly related to long-term
health-related quality of life.
1,2 This is also true for a
history of psychiatric disorders
3 and maladaptive
coping.
3,4 The reported prevalence of psychopathol-
ogy differs between studies. For example, the
prevalence of depression varies from 5% after 2
years,
5 9% after 9 months
6 and 9 years,
7 10% after 18
months,
8 to 20% after 16 months.
9 Furthermore,
a systematic review of 53 observational studies
indicates that about one-third of patients with stroke,
irrespective of its cause, report depression.
10 Pre-
valence ﬁgures for PTSD after SAH show even
greater variation, with studies reporting from 6%,
6
19%,
11 32%,
12 to 60%.
8
There are several possible explanations for these
reported discrepancies. First, the patients’ level of
mental well-being prior to SAH onset is regularly
neglected, despite the fact that a lifetime history of
psychiatric disorders is common in the general
population.
13–15 Studies that overlook this fact may
mistakenly blame post-SAH psychiatric problems on
the SAH itself or on its consequences, when in
reality, they were already present before the onset of
the SAH. Furthermore, current literature suggests,
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DOI: 10.3109/02688697.2011.578769from different angles, that a previous psychiatric
history is an indicator of an increased vulnerability
for having mental problems, particularly in con-
nection with stressful events.
16–19 Second, metho-
dological problems such as the use of non-
standardised measures, and varying time points for
assessment, also contribute to disparate ﬁndings.
Third, the issue of psychological or pharmacologic
treatment is not addressed as an integral factor
when rates of psychiatric disorders are evaluated
after SAH.
The uncertainty involved in interpreting previous
reports motivates a rigorous approach to achieve a
population-based SAH sample for a longitudinal
analysis of psychopathology assessed by clinician-
administered semi-structured interviews using strict
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) criteria.
20 We therefore
comprehensively assessed premorbid prevalences of
lifetime and 12-month psychiatric axis I disorders in
subjects consecutively admitted to a neurointensive
care unit (NICU) receiving all SAH patients from a
deﬁned catchment area. In addition, we prospec-
tively assessed the occurrence of psychiatric axis I
disorders, particularly minor and major depressions
as well as subsyndromal and full PTSD, on average 7
months after the SAH. We hypothesised that a
history of any psychiatric disorder before the SAH
predicts the occurrence of depression and PTSD 7
months after SAH.
Materials and methods
Participants
Consecutive patients with acute SAH, admitted to
the Department of Neurosurgery, Uppsala University
Hospital, between September 2002 and October
2005 were assessed. Uppsala University Hospital
covers a geographical area with approximately
1,900,000 inhabitants. The incidence rates of spon-
taneous SAH and of ruptured aneurysms are 7.7 and
5.5/100,000/year, respectively.
21 Inclusion criteria
were the following: (i) Swedish speaking; (ii) age
between 18 and 75 years; (iii) having been treated by
clipping or coiling after a ﬁrst time aneurysmal SAH
and (iv) awake and devoid of apparent cognitive
dysfunction (Reaction Level Scale (RLS85): 1–2; at
the very most drowsy, but not confused).
22 Patients
admitted on a temporary basis, who had their main
care elsewhere, were not included.
Study design and procedure
The study design was prospective with a focus on
those with an expected good prognosis. While still
in the Department of Neurosurgery, patients were
approached concerning participation in the study
as soon as their medical condition allowed. Those
who gave informed consent were subsequently
interviewed twice. The ﬁrst interview was per-
formed within the ﬁrst 10 days and concerned
sociodemographic data, and the second inter-
view was performed 7 months (mean 6.8+1.9;
mean+SD) thereafter and included psychiatric
status and an examination to exclude apparent
cognitive dysfunction. The study complied with
the principles of the Helsinki Declaration and
was approved by the Uppsala University Ethics
Committee.
Outcome measures
The psychiatric outcome measure was the Structured
Clinical Interview for DSM-IV axis I disorders
(SCID-I).
23 SCID-I is one of the most widely used
and thoroughly researched psychiatric clinical inter-
views
24 and is based on operationalised criteria
deﬁned in the DSM-IV.
25 SCID-I interview was
used to assess diagnoses for three time periods. The
‘lifetime’ prevalence is the proportion of patients in
the sample who met criteria for a given diagnosis at
any time in their life before and including the time of
SAH onset. The ‘12-month’ prevalence is the
proportion of patients in the sample who met criteria
for a diagnosis at some time during the 12 months
before and including the time of SAH onset. Finally,
the prevalence ‘7 months after SAH’ is the propor-
tion of patients in the sample who met diagnostic
criteria for a given diagnosis at the time of the
interview. This time was chosen for follow-up
because it is a time when patients with an expected
good outcome are likely to have ‘objectively’ recov-
ered neurologically and to be well beyond the acute
episode. Furthermore, at the chosen time point, the
DSM-IV diagnostic criteria for depressive symptoms
have been found to have good speciﬁcity (98%),
sensitivity (100%) and a positive predictive value of
80% compared to gold standard diagnostics 6
months post-stroke.
26 In the psychiatric interview,
minor depression and subsyndromal PTSD were also
registered. The DSM-IV criteria for minor depres-
sion were applied, i.e. presence of either depressed
mood or loss of interest and two to four depressive
symptoms and an indicator of functional impair-
ment. A subsyndromal PTSD diagnosis was based
on the criteria speciﬁed by Mylle and Maes,
27
requiring the presence of the re-experiencing symp-
tom cluster and at least one symptom from the
avoidance and the arousal symptom clusters, and an
indicator of functional impairment.
27
All patients were interviewed by a psychiatric nurse
specialist (MH), with education and training in
performing SCID-I interviews and assessments. All
patients were interviewed at a place of their own
choice. Consequently, 53 (64%) interviews were
performed at the Uppsala University Hospital, 24
(29%) in the patients’ home, 2 (2%) at another
hospital, and 4 (5%) patients preferred a telephone
interview.
694 M. Hedlund et al.Statistical analysis
The clinical parameters evaluated were age, sex, the
amount of blood on the ﬁrst CT scan deﬁned by the
Fisher grade,
28 the neurological condition scored
using the World Federation of Neurosurgical Socie-
ties (WFNS) Committee scale
29 and as the level on
the RLS85
22 assessed at admission to and discharge
from the NICU. We also recorded whether the
aneurysm was treated with surgical or endovascular
technique, whether intraventricular drainage was
used and whether treatment of presumed vasospasm
was given.
30 For a summary of the patients’
characteristics at baseline see Table I.
The independent effect of psychiatric morbidity
before the SAH on psychiatric morbidity 7 months
after SAH was analysed using logistic regression. To
increase power in the analyses, major and minor
depressions on the one hand and subsyndromal and
full PTSD on the other were aggregated and used as
dependent variables. Clinical parameters were ad-
justed for in the regressions by considering them as
independent covariates, provided there was a p-
value50.25 in bivariate regressions.
31 All data were
analysed using SPSS 17.0.
Results
Of the 325 patients with SAH who were admitted
during the study period, 129 met criteria for
inclusion (Fig. 1). Of this group, 36 (28%) were lost
before screening. Three of them declined participa-
tion, and 33 were not approached due to adminis-
trative reasons. The remaining 93 patients (72%)
were included. There were no statistically signiﬁcant
differences between the 93 included patients and the
36 who were lost regarding sex, age or SAH
characteristics (data not shown).
Ten patients were lost to follow-up when ap-
proached after 7 months. Those who were lost were
older (p¼0.02) as compared to those not lost, but
did not differ with respect to sex, WFNS or Fisher
grade.
Lifetime psychiatric disorders
Of the 83 patients, 37 (45%) presented with at least
one psychiatric disorder any time before SAH; major
depression and alcohol abuse or dependence were
most common (Table II). Psychiatric comorbidity,
deﬁned as fulﬁlment of criteria for more than one
disorder, was present in 17 of the 37 patients (46%).
The 12-month prevalence rates for DSM-IV
disorders were, as expected, lower than the lifetime
prevalence rates. Sixteen (19%) of the total sample,
however, fulﬁlled criteria for at least one diagnosis
during the year preceding SAH; simple and social
phobias were most common.
Psychiatric disorders at seventh month after SAH
At seventh month after SAH, 34 patients (41%)
presented with at least one psychiatric disorder, of
whom, 6 were without psychiatric history before the
SAH, and another eight patients met criteria for a
subsyndromal diagnosis (Table II).
Major depression was the most frequent diagnosis
and was present in 17 (20%) of the 83 patients. Ten
of these had a lifetime history of depression, 1 of
whom had an ongoing depression at the time of the
SAH. Four patients experienced minor depression at
the time of follow-up.
A diagnosis of SAH-related PTSD was present in
15 patients (18%) at follow-up, and another 10
patients (10%) met diagnostic criteria for subsyn-
dromal PTSD. Of the 15 patients with full PTSD,
four had experienced PTSD previously in their
lifetime, one of whom had an ongoing PTSD. Seven
of these 15 patients also met the DSM-IV criteria for
major depression.
The longitudinal courses of major and minor
depressions as well as PTSD and subsyndromal
PTSD in the 83 patients included in the 7-month
follow-up examination are portrayed in Figs. 2 and 3
using a presentation similar to that given by Schnyder
U et al.
32
TABLE I. Patient characteristics
Included (N)9 3
Death 72
Dysphasia 72
Did not want to participate 72
Not available 74
Study population 83
Males/females 30/53
Mean age in years 52 (SD¼9, range 30–74)
RLS85 at admission
16 3
21 4
33
4o r5 3
RLS85 at discharge
17 3
29
31
Fisher grade
I–II 22
III–IV 61
WFNS
16 3
21 4
31
4o r5 5
Ventricular drainage 30
Vasospasm 15
Type of aneurysm occlusion
Surgery 29
Coiling 54
Work status at SAH onset
Full-time/part time 44/22
Student 1
Retired 6
Sick leave or disability pension 10
Depression and PTSD after SAH 695Considered together, at follow-up, 34 (41%)
patients exhibited symptoms of depression in the
form of minor or major depression and/or PTSD in
the form of subsyndromal or full PTSD, while 49
patients did not. Twenty-four of those 34 patients
had a psychiatric history prior to the SAH compared
to 13 of the 49 patients (w
2¼15.8; p¼0.001).
Logistic regressions revealed that a depressive
disorder at seventh month was predicted by the
presence of a lifetime history of major depression, a
lifetime anxiety disorder, a lifetime substance use
disorder, any lifetime psychiatric disorder and life-
time psychiatric comorbidity (Table III). Subsyndro-
mal or full PTSD at seventh month was only
predicted by a lifetime history of major depression
and of any lifetime psychiatric disorder. Similar re-
sults were obtained irrespective of whether the inde-
pendent predictors (see statistics section) were forced
into the models (Table III) or whether a forward
stepwise regression (data not shown) was used.
None of the disorder groups present that 12
months prior to SAH was signiﬁcantly related to a
depressive disorder, or to subsyndromal or full
PTSD at seventh month.
Psychiatric treatment and work status
Nineteen patients (23%) reported a history of
receiving psychiatric care before SAH onset; eight
of them had been hospitalised. A total of 12 patients
had previous treatment with antidepressants, six
reported sedative treatment, and 1 reported treat-
ment with antipsychotic drugs. Seven participants
had ongoing antidepressant treatment at the time of
SAH, ﬁve of whom did not fulﬁl criteria for major or
minor depression at seventh month after SAH.
During the ﬁrst 7 months after SAH, 18 patients
(22%) had received psychotropic medication and/or
psychological treatment due to psychiatric symptoms
related to SAH, and 13 of them fulﬁlled criteria for a
FIG. 1. Flow chart of patients through each stage of the study presented according to the Consolidated Standards of Reporting Trials
(CONSORT) statement (www.consort-statement.org/).
TABLE II. Prevalence rates of psychiatric diagnoses in the 83
patients admitted to the NICU
Life-
time
12
months
prior to
SAH
onset
7-month
follow-up
N % N % N %
Any affective disorders 22 27 4 5 17 21*
Major depressive episode 22 27 3 4 17 21
Minor depressive episode na na na na 4
{ 5
Manic or hypomanic episode 1 1 1 1 0 0
Dysthymia 2 2 0 0 0 0
Any anxiety disorder 22 27 11 13 26 31*
PTSD 7 8 1 1 15 18
Subsyndromal PTSD na na na na 10
{ 12
Panic disorder 6 7 1 1 2 2
Social phobia 6 7 6 7 6 7
Simple phobia 6 7 6 7 6 7
Psychosis UNS
(not otherwise speciﬁed) 1 1 0 0 0 0
Any substance use disorder 11 13 3 4 3 4
Alcohol abuse/dependency 10 12 2 2 2 2
Drug abuse/dependency 4 5 1 1 1 1
Eating disorder 1 1 1 1 1 1
At least one disorder 37 45 16 19 34* 41*
na, not assessed.
*Minor depression and subsyndromal PTSD not accounted for.
{Of whom, two had another disorder and one had subsyndromal
PTSD.
{Of whom, three had another disorder and one had minor
depression.
696 M. Hedlund et al.disorder at seventh month. Treatment was more
common among those who fulﬁlled criteria for a
lifetime psychiatric disorder (w
2¼17.1; p50.001) or
a psychiatric disorder at seventh month after SAH
(w
2¼9.3; p¼0.002).
Of the 83 patients, 67 had worked or were engaged
in full-time studies prior to the SAH. Those with a
lifetime history of major depression or treatment with
antidepressants any time prior to the SAH had a
lower return-to-work rate than the remaining pa-
tients. Thus, only two of the 25 who had a lifetime
history of major depression had returned to work
compared to 14 of the 42 who did not have such a
history (w
2¼5.5; p¼0.019). Seven of the 67 who had
worked or were engaged in full-time studies had
received antidepressant medication any time before
the SAH. None of those seven were working at
seventh month after SAH (w
2¼4.7; p¼0.031).
Furthermore, those who had minor or major
depression and/or PTSD in the form of subsyndromal
or full PTSD at seventh month after SAH had a lower
return-to-work rate than the remaining patients. Four
of those 29 patients had returned to work 7 months
afterSAHcomparedto21ofthe38withnodepressive
FIG. 2. Number of patients with diagnoses of depression with respect to lifetime, 12 months prior to the SAH, and at follow-up 7 months
after the SAH in the 83 investigated patients. Note: Presentation as in Schnyder et al.
32 Numerals are numbers of patients; sizes of squares
and arrows represent quantitative proportions.
FIG. 3. Number of patients with diagnoses of PTSD, subsyndromal PTSD and no PTSD with respect to lifetime, 12 months prior to the
SAH, and at follow-up 7 months after the SAH in the 83 investigated patients. Note: Presentation as in Schnyder et al.
32 Numerals are
numbers of patients; sizes of squares and arrows represent quantitative proportions.
Depression and PTSD after SAH 697and/or PTSD symptoms (w
2¼12.1; p¼0.001). Fi-
nally,sevenofthe67whohadworkedorwereengaged
in full-time studies prior to the SAH had ongoing
antidepressant treatment, and none had returned to
work at seventh month (w
2¼4.7; p¼0.031).
Discussion
Key results of the present study are that psychiatric
disorders are common after SAH, particularly
symptoms of depression and PTSD, which affected
41% of our patients, and that only a fraction of these
patients receive treatment. Furthermore, those who
exhibit a history of previous psychiatric morbidity, or
treatment, constitute a group with considerable risk
of inadequate adaptation after their SAH.
Forty-ﬁve percentage of the investigated patients
were diagnosed with a lifetime psychiatric disorder,
and 19% had suffered from at least one psychiatric
disorder the year before the SAH. This is within the
range of previously reported population-based epi-
demiological surveys from Norway
14,15 and the
United States.
13
The prevalence of major and minor depressions at
seventh month after SAH was 25%. This ﬁgure is in
accord with what has previously been reported after
stroke in general,
10,26 but is higher than previously
reported ﬁgures for SAH that vary from 5% after 2
years
5 to 20% after 16 months.
9 At least two aspects
of this ﬁnding can be highlighted. First, differences in
results may be the result of a ‘lack of standard
methods’.
10,26 Second, SAH is more common in
women,
21 who present a higher risk than men for
major depression.
13 The estimated prevalence of
PTSD 7 months after SAH was 18%, which is similar
to the previously reported ﬁgure of 19% after 3
months,
11 but less than the 37% reported after 3
months and 13 months.
2
The aggregation of minor and major depressions
on the one hand and subsyndromal PTSD and full
PTSD on the other was done for two reasons. First, it
increased the statistical power. Second, individuals
with minor depression or subthreshold PTSD exhibit
clinically signiﬁcant suffering. Those with minor
depression often have a history of major depressive
disorder and are at risk of developing major
depressive disorder later on.
33 A similar situation
prevails for those with subthreshold PTSD. The
PTSD concept in the DSM-IV has been criticised for
being too restrictive, since a number of those afﬂicted
who do not fulﬁl the diagnostic criteria for full PTSD
will display clinically signiﬁcant suffering
27 and run
the risk of delayed onset of full PTSD.
34
Those with a lifetime history of psychiatric mor-
bidity were at considerably higher risk for new
symptoms after their SAH. Previous research indi-
cates that those afﬂicted by psychiatric sequelae after
SAH constitute a risk group for not reintegrating to
their normal life.
35 In particular, younger stroke
survivors suffering from psychiatric sequelae starting
within a month after their stroke seem to fail to return
to work.
36 Interestingly, in the present study, those
with a lifetime history of any affective disorder prior to
the SAH reported difﬁculties in returning to work.
This indicates a possibility for identifying, as early as
during acute care, a high-risk group for rehabilitation
problems. Only 13 of the 34 participants in the study
population who presented with a disorder at seventh
month had received pharmacological or psychological
treatment after SAH onset, which suggests that there
is room for substantial improvement in care. Further-
more, previous research indicates that psychosocial
difﬁculties in the aftermath of SAH are associated
with gaps in community-based support.
37 In that
respect, nursing support has proven beneﬁcial in
reducing patients’ suffering.
38 However, there is a risk
that those with an expected good prognosis will miss
out on nursing support.
39,40 Moreover, SAH patients
exposed to neurointensive care display signs of
PTSD.
41 Early psychosocial support is suggested to
reduce such reactions.
41
The study has some limitations. First, only 64% of
all eligible patients could be investigated at seventh
month. However, the dropouts did not differ from
those included except for age. Second, the strict
inclusion of participants with a good neurological
status in the form of an RLS85 of 1 or 2 during acute
care makes the conclusions applicable only to the
TABLE III. Logistic regressions with the presence of minor and major depressions, as well as subsyndromal and full PTSD at follow-up 7
months after SAH as dependent variables, and the presence of lifetime psychiatric disorders before SAH as independent variables
Lifetime disorders
Minor or major
depression* Subsyndromal or full PTSD
{
OR 95% CI p OR 95% CI p
Lifetime affective disorder 11.9 3.0–46 0.001 7.5 2.3–24 0.001
Lifetime anxiety disorder 6.5 1.6–26 0.008 2.0 0.6–6.0 ns
Lifetime substance use disorder 9.8 1.5–66 0.019 2.0 0.5–8.0 ns
Any psychiatric disorder lifetime 14.1 3.0–66 0.001 4.4 1.5–13 0.007
Psychiatric comorbidity 10.1 2.2–47 0.003 2.1 0.6–7.1 ns
Note: Clinical predictors with p50.25 in simple binary regressions were adjusted for by forcing them into regressions as independent
variables. OR, odds ratio; CI, conﬁdence interval; ns, not signiﬁcant.
*Adjusted for Fisher grade, WFNS, ventricular drainage, vasospasm and female sex.
{Adjusted for WFNS and female sex.
698 M. Hedlund et al.group of patients with expected good outcome.
Third, this study, similar to previous studies on
predictors of depression in the aftermath of stroke,
42
can be criticised for its small sample size. Fourth,
studies on assessments of the occurrence of lifetime
psychiatric disorders always run the risk of under-
reporting of prior episodes due to recall bias.
43
The most obvious strengths of the study are its
prospective design and that it is the ﬁrst of its kind.
The role of prior lifetime psychiatric morbidity
regarding problems after SAH has not previously
been assessed utilising an appropriate instrument and
DSM-IV criteria.
There is need for further studies on how to
organise post-SAH care in such a way that each
individual is given optimal possibilities for returning
to an active life in society. Underdiagnosis, and
insufﬁcient awareness of the importance of previous
psychiatric history, should receive particular consid-
eration in such studies.
Conclusion
Depression and PTSD are present in a substantial
proportion of patients 7 months after SAH. Those
with a lifetime history of psychiatric morbidity before
their SAH are more at risk for such conditions and
also constitute a risk group for difﬁculties in
returning to work.
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